Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structure supports binding to specific neuronal receptors, making it valuable in developing potential treatments for pain, depression, and epilepsy. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity of drug candidates. Also utilized in radiolabeled forms for receptor binding assays and pharmacokinetic evaluations.